Nazareth S, Hayward L, Simmons E, Snir M, Hatchell KE, Rojahn S, Nussbaum RL (2021) Hereditary cancer risk using a genetic chatbot before routine care visits. Obstet Gynecol 138:860–870. https://doi.org/10.1097/AOG.0000000000004596

Article  PubMed  PubMed Central  Google Scholar 

Rao SK, Blakely LJ, Small K, Schleicher S, Natalie RDM (2024) Building efficiency and scaling with a remote genetic counseling program. Oncol (Williston Park) 38:20–25. https://doi.org/10.46883/2024.25921011

Article  Google Scholar 

Raspa M, Moultrie R, Toth D, Haque SN (2021) Barriers and facilitators to genetic service delivery models: scoping review. Interact J Med Res 10:e23523. https://doi.org/10.2196/23523

Article  PubMed  PubMed Central  Google Scholar 

National Comprehensive Cancer Network (2025) Genetic/familial high-risk assessment: breast, ovarian, pancreatic, and prostate. https://www.nccn.org/guidelines/guidelines-detail?category=2&id=1545

Radford C, Prince A, Lewis K, Pal T (2014) Factors which impact the delivery of genetic risk assessment services focused on inherited cancer genomics: expanding the role and reach of certified genetics professionals. J Genet Couns 23:522–530. https://doi.org/10.1007/s10897-013-9668-1

Article  PubMed  Google Scholar 

Cohen SA, Huziak RC, Gustafson S, Grubs RE (2016) Analysis of advantages, limitations, and barriers of genetic counseling service delivery models. J Genet Couns 25:1010–1018. https://doi.org/10.1007/s10897-016-9932-2

Article  PubMed  Google Scholar 

Buchanan AH, Datta SK, Skinner CS, Hollowell GP, Beresford HF, Freeland T, Adams MB (2015) Randomized trial of telegenetics vs in-person cancer genetic counseling: cost, patient satisfaction and attendance. J Genet Couns 24:961–970. https://doi.org/10.1007/s10897-015-9836-6

Article  PubMed  PubMed Central  Google Scholar 

Danylchuk NR, Cook L, Shane-Carson KP, Cacioppo CN, Hardy MW, Nusbaum R, Malinowski J (2021) Telehealth for genetic counseling: a systematic evidence review. J Genet Couns 30:1361–1378. https://doi.org/10.1002/jgc4.1481

Article  PubMed  Google Scholar 

Proussaloglou EM, Koelliker EL, Laprise J, Wilbur JS, Robison K, Stuckey A, Crawford K (2024) The impact of converting to telehealth for cancer genetic counseling and testing during the COVID-19 pandemic. J Genet Couns 33:834–841. https://doi.org/10.1002/jgc4.1792

Article  PubMed  Google Scholar 

Kinney AY, Steffen LE, Brumbach BH, Kohlmann W, Du R, Lee JH, Schwartz MD (2016) Randomized noninferiority trial of telephone delivery of BRCA1/2 genetic counseling compared with in-person counseling: 1-year follow-up. J Clin Oncol 34:2914–2924. https://doi.org/10.1200/JCO.2015.65.9557

Article  PubMed  PubMed Central  Google Scholar 

Lahiri S, Mersch J, Zimmerman J, Mauer Hall C, Moriarty K, Gemmell A, Pirzadeh-Miller S (2025) Randomized control trial comparing genetic counseling service delivery models in an underserved population. J Genet Couns 34:e1975. https://doi.org/10.1002/jgc4.1975

Article  PubMed  Google Scholar 

Wang C, Lu H, Bowen DJ, Xuan Z (2023) Implementing digital systems to facilitate genetic testing for hereditary cancer syndromes: an observational study of 4 clinical workflows. Genet Med 25:100802. https://doi.org/10.1016/j.gim.2023.100802

Article  CAS  PubMed  Google Scholar 

Williams S, Ebrahimzadeh JE, Clay D, Constantino G, Heiman J, Wangensteen KJ, Katona BW (2023) Comparing telemedicine and in-person gastrointestinal cancer genetic appointment outcomes during the COVID-19 pandemic. Hered Cancer Clin Pract 21:6. https://doi.org/10.1186/s13053-023-00250-8

Article  PubMed  PubMed Central  Google Scholar 

Chapman-Davis E, Zhou ZN, Fields JC, Frey MK, Jordan B, Sapra KJ, Holcomb KM (2021) Racial and ethnic disparities in genetic testing at a hereditary breast and ovarian cancer center. J Gen Intern Med 36:35–42. https://doi.org/10.1007/s11606-020-06064-x

Article  PubMed  Google Scholar 

Peterson JM, Pepin A, Thomas R, Biagi T, Stark E, Sparks AD, Kaltman R (2020) Racial disparities in breast cancer hereditary risk assessment referrals. J Genet Couns 29:587–593. https://doi.org/10.1002/jgc4.1250

Article  PubMed  Google Scholar 

Grzymski JJ, Elhanan G, Morales Rosado JA, Smith E, Schlauch KA, Read R, Lu JT (2020) Population genetic screening efficiently identifies carriers of autosomal dominant diseases. Nat Med 26:1235–1239. https://doi.org/10.1038/s41591-020-0982-5

Article  CAS  PubMed  Google Scholar 

Abul-Husn NS, Soper ER, Odgis JA, Cullina S, Bobo D, Moscati A, Kenny EE (2019) Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank. Genome Med 12:2. https://doi.org/10.1186/s13073-019-0691-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manchanda R, Blyuss O, Gaba F, Gordeev VS, Jacobs C, Burnell M, Jacobs I (2018) Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population. J Med Genet 55:538–545. https://doi.org/10.1136/jmedgenet-2017-105195

Article  PubMed  Google Scholar